Discover

LUCD
Lucid Diagnostics Inc.
0.97
13 x 0.97
4 x 0.97
bid
ask
+
0.01
0.57%
01:35 PM
timesize
Ytd-11.32%
1y-3.15%
0.97
day range
0.99
0.86
52 week range
1.63
Open0.98Prev Close0.96Low0.97High0.99Mkt Cap184.40M
Vol451.20KAvg Vol1.46MEPS-0.37P/E-2.61Forward P/E-1.12
Beta1.08Short Ratio0.80Inst. Own4.18%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg0.99200-d Avg1.131yr Est3.50

LUCD News

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test
prnewswire.com
Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard

Concert's policy recognizes EsoGuard ® as the only esophageal precancer test meeting its coverage cr

Lucid Diagnostics to Participate in Upcoming Investor Conferences
prnewswire.com
Lucid Diagnostics to Participate in Upcoming Investor Conferences

NEW YORK, Aug. 4, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD) ("Lucid" or the "Compa

PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026
prnewswire.com
PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026

Conference Call and Webcast at 8:30 AM ET NEW YORK, July 31, 2026 /PRNewswire/ -- PAVmed Inc.  (Nasd

Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026
prnewswire.com
Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August

Conference Call and Webcast at 8:30 AM ET NEW YORK, July 30, 2026 /PRNewswire/ -- Lucid Diagnostics

Lucid Diagnostics: Positioned For A Medicare-Driven Inflection
seekingalpha.com
Lucid Diagnostics: Positioned For A Medicare-Driven Inflection

Lucid Diagnostics offers asymmetric upside, with Medicare reimbursement as a near-term inflection po

Lucid Diagnostics Inc. (LUCD) Shareholder/Analyst Call Prepared Remarks Transcript
seekingalpha.com
Lucid Diagnostics Inc. (LUCD) Shareholder/Analyst Call Prepared Remarks Transcript

Lucid Diagnostics Inc. (LUCD) Shareholder/Analyst Call Prepared Remarks Transcript

PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results
prnewswire.com
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results

Veris Health progressed commercial expansion and advanced implantable physiological monitor developm

Lucid Diagnostics Inc. (LUCD) Q1 2026 Earnings Call Transcript
seekingalpha.com
Lucid Diagnostics Inc. (LUCD) Q1 2026 Earnings Call Transcript

Lucid Diagnostics Inc. (LUCD) Q1 2026 Earnings Call Transcript

Lucid Diagnostics Q1 Earnings Call Highlights
marketbeat.com
Lucid Diagnostics Q1 Earnings Call Highlights

Lucid Diagnostics NASDAQ: LUCD reported first-quarter 2026 EsoGuard test volume above its pre-Medica

Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates
zacks.com
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates

Lucid Diagnostics Inc. (LUCD) came out with a quarterly loss of $0.07 per share versus the Zacks Con

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
prnewswire.com
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

Processed 3,177 EsoGuard ® tests and recognized 1Q26 revenue of $1.3 million, ending quarter with $4

Earnings Scheduled For May 14, 2026
benzinga.com
Earnings Scheduled For May 14, 2026

Lucid Diagnostics Inc. (LUCD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
zacks.com
Lucid Diagnostics Inc. (LUCD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Rele

Lucid Diagnostics (LUCD) doesn't possess the right combination of the two key ingredients for a like

PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026
prnewswire.com
PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026

Conference Call and Webcast at 8:30 AM ET NEW YORK, May 1, 2026 /PRNewswire/ -- PAVmed Inc.  (Nasdaq

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026
prnewswire.com
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14,

Conference Call and Webcast at 8:30 AM ET NEW YORK, April 30, 2026 /PRNewswire/ --  Lucid Diagnostic

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock
prnewswire.com
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

NEW YORK, April 24, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD) ("Lucid" or the "Com

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock
prnewswire.com
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

NEW YORK, April 23, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD) ("Lucid" or the "Com

Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of “Moderate Buy” from Analysts
defenseworld.net
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Lucid Diagnostics Inc. (NASDAQ: LUCD - Get Free Report) have received an average recommend

Texas Instruments To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
benzinga.com
Texas Instruments To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday

Top analysts change outlook on top names, like AA, SSSS, TXN, HQY, LUCD, RPM, PAR, ASRT. Morgan Stan

Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
prnewswire.com
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conf

NEW YORK, April 9, 2026 /PRNewswire/ --  Lucid Diagnostics Inc.  (Nasdaq: LUCD) ("Lucid" or the "Com

PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
prnewswire.com
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio

Medtech industry veteran to oversee development and commercialization of PAVmed's current and future

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
prnewswire.com
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

PAVmed strengthened its capital structure and relaunched its medical device portfolio under new lead

Earnings Scheduled For March 26, 2026
benzinga.com
Earnings Scheduled For March 26, 2026

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Earnings Scheduled For November 12, 2025
benzinga.com
Earnings Scheduled For November 12, 2025

benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
Earnings Scheduled For August 13, 2025

benzinga.com
Earnings Scheduled For May 14, 2025

benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
Earnings Scheduled For November 13, 2024

benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga.com
Earnings Scheduled For November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its

benzinga.com
Earnings Scheduled For August 14, 2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q

benzinga.com
Earnings Scheduled For May 15, 2023

Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings f

benzinga.com
Earnings Scheduled For November 14, 2022

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  During Monday's session, 402 companies made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 930 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 1076 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 507 stocks hit new 52-week lows.

benzinga.com
Earnings Scheduled For May 11, 2022

  Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earn

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 1043 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 431 companies hit new 52-week lows.

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021

 

benzinga.com
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, I

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched